Table 2

Prescription, patient, family physician and primary care centre characteristics included in the study (January 2011 to June 2014)

Prescriptions n=10 652 213%
 Total new prescriptions for all medications* 10 652 213100
 Medication subgroups
 Medication for chronic physical conditions 1 230 37111.55
 Analgesics (anilides and propionic acid derivatives)5 323 76149.98
 Penicillin1 258 57711.82
 PPIs1 293 90412.15
 Benzodiazepines950 8908.93
 SSRIs389 9673.66
 Other antiepileptics204 7431.92
Patients n=3 075 364 %
 Gender (female)1 679 89354.62
 Age (mean±SD)50.6118.90
 Copayment grade
 Poor population (0%)205 0066.67
 Low-middle income pensioners (10%)962 62231.30
 Low-income non-pensioners (40%)1 349 22243.87
 Middle-income non-pensioners (50%)505 59717.86
 High-income population (60%)92710.30
 Area socioeconomic status
 Urban 1449 11714.60
 Urban 2498 00116.19
 Urban 3512 45016.66
 Urban 4524 85517.07
 Urban 5516 09116.78
 Rural574 77218.69
 Nationality
 Spaniard2 463 22080.10
 American250 9068.16
 Asian/Oceanian65 5272.13
 Other European123 2484.01
 African172 3855.61
 Active diseases
 Allergy73 8232.40
 Pain1 086 04935.32
 Respiratory disease252 7588.22
 Disability506 42216.47
 Cardiovascular1 551 82450.46
 Mental disorder688 58122.39
 Neurological249 9938.13
 Diabetes mellitus302 1759.83
 Digestive system disorder392 93112.78
 Thyroid gland-related disease177 4565.77
 Number of grouped comorbidities (mean±SD)1.721.48
Family physician characteristics n=10 936 %
 Gender (female)751468.71
 Age (mean±SD)42.9510.29
 Assigned FPs376734.45
Primary care centre characteristics n=295 %
 Teaching centre7224.41
  • *All medications include (ATC code): insulins and analogues for injection; long-acting (A10AE); platelet aggregation inhibitors excluding heparin (B01AC); ACE inhibitors, plain (C09AA); HMG CoA reductase inhibitors (C10AA); adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics (R03AK); anticholinergics (R03BB); PPIs (A02BC); propionic acid derivatives (M01AE); anilides (N02BE); other antiepileptics (N03AX); selective serotonin reuptake inhibitors (N06AB); benzodiazepine derivatives (N05BA); and penicillin with extended spectrum (J01CA).

  • †Medication for chronic physical conditions includes: long-acting insulins and analogues for injection; platelet aggregation inhibitors excluding heparin; plain ACE inhibitors; HMG CoA reductase inhibitors; adrenergics in combination with corticosteroids or other drugs excluding anticholinergics; anticholinergics.

  • FP, family physician; PPI, proton pump inhibitor; SSRI, selective serotonin reuptake inhibitor.